PharmaNanoGene: Farmacocinética, Nanotecnología y Terapia Génica
Hospital de Cruces
Barakaldo, EspañaHospital de Cruces-ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2023
-
Autoimmune Diabetes From Childhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype
The Journal of clinical endocrinology and metabolism, Vol. 108, Núm. 11, pp. e1341-e1346
2022
-
Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability
Antibiotics, Vol. 11, Núm. 5
-
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
Journal of Intensive Care, Vol. 10, Núm. 1
2021
2018
-
Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
Clinical Pharmacokinetics, Vol. 57, Núm. 9, pp. 1107-1121
2013
-
Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: Pharmacokinetic considerations and patient pathophysiology
International Journal of Clinical Pharmacology and Therapeutics, Vol. 51, Núm. 7, pp. 606-614
-
Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction
European Journal of Clinical Pharmacology, Vol. 69, Núm. 1, pp. 65-74
2011
-
Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation
European Journal of Clinical Pharmacology, Vol. 67, Núm. 7, pp. 671-679
2005
-
Bicompartmental kinetics of tobramycin analysed with a wide range of covariates
International Journal of Antimicrobial Agents, Vol. 26, Núm. 4, pp. 304-311
2002
-
'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction
European Journal of Clinical Pharmacology, Vol. 58, Núm. 9, pp. 615-619